HARSHAVARDHAN DODDAPANENI to Proteogenomics
This is a "connection" page, showing publications HARSHAVARDHAN DODDAPANENI has written about Proteogenomics.
Connection Strength
0.386
-
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers. Cell Rep Med. 2025 Jun 17; 6(6):102154.
Score: 0.210
-
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Cancer Discov. 2022 11 02; 12(11):2586-2605.
Score: 0.176